SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-622550
Filing Date
2016-06-15
Accepted
2016-06-15 16:46:04
Documents
6
Period of Report
2016-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d212800d8k.htm 8-K 20263
2 EX-1.1 d212800dex11.htm EX-1.1 202526
3 EX-5.1 d212800dex51.htm EX-5.1 14866
4 EX-99.1 d212800dex991.htm EX-99.1 5385
5 GRAPHIC g212800g50h09.jpg GRAPHIC 11506
6 GRAPHIC g212800g87e39.jpg GRAPHIC 9364
  Complete submission text file 0001193125-16-622550.txt   262469
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36819 | Film No.: 161715744
SIC: 2836 Biological Products, (No Diagnostic Substances)